Normolose (Captopril)

Captopril, the active ingredient in Normolose, is an ACE inhibitor presented as an oral tablet for systemic use. It is used to lower high blood pressure and to improve outcomes in heart failure and after myocardial infarction, particularly in adult patients, and is indicated for patients requiring long‑term blood pressure control.

GNH USA supplies Normolose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Captopril is an ACE inhibitor used to manage conditions related to the renin‑angiotensin‑aldosterone system.

- Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. - Heart failure: improves cardiac output, reduces symptoms and hospitalizations. - Post‑myocardial infarction: decreases the likelihood of subsequent cardiovascular events and supports ventricular remodeling.

Captopril may cause a range of adverse reactions.

Common Side Effects: - Cough: persistent dry cough. - Dizziness: especially upon standing. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of the face, lips, tongue or airway. - Severe hypotension: marked drop in blood pressure. - Neutropenia: reduced white blood cell count. - Hyperkalemia: elevated potassium levels in the blood.

Before initiating therapy with Normolose, consider the following precautions.

- Renal function monitoring: assess serum creatinine and eGFR regularly. - Electrolyte monitoring: watch for hyperkalemia, especially with potassium‑sparing agents. - History of angioedema: avoid use in patients with prior ACE‑inhibitor‑induced angioedema. - Pregnancy considerations: use only if potential benefit justifies the risk, as safety data are limited. - Concomitant NSAIDs: may increase risk of renal impairment and attenuate antihypertensive effect. - Store at room temperature: keep in the original pack, protect from moisture.

Captopril can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of dangerous hyperkalemia. - Aliskiren (in diabetic patients): increased risk of renal dysfunction. - High‑dose NSAIDs: may reduce antihypertensive efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - Lithium: captopril can raise lithium concentrations, risking toxicity. - Thiazide diuretics: may enhance hypotensive effect and electrolyte disturbances.